Nephros (NEPH) Stock Coverage Initiated with $4 Price Target

Northland initiated coverage of Nephros (NEPH) with a price target of $4. This new estimate suggests potential upside for investors who hold or consider purchasing the stock. The initiation of coverage typically indicates analysts' confidence in a stock's performance. For ordinary investors, this pricing target gives insight into Nephros's anticipated valuation in the market.